CLNN
Clene Inc. - Common Stock (CLNN)
$54
About Clene Inc. - Common Stock (CLNN)
Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.
Details
Daily high
$4.70
Daily low
$4.40
Price at open
$4.40
52 Week High
$13.50
52 Week Low
$3.25
Market cap
55.9M
Dividend yield
-
Volume
102,747
Avg. volume
145,501
P/E ratio
-1.24
Clene Inc. - Common Stock News
Details
Daily high
$4.70
Daily low
$4.40
Price at open
$4.40
52 Week High
$13.50
52 Week Low
$3.25
Market cap
55.9M
Dividend yield
-
Volume
102,747
Avg. volume
145,501
P/E ratio
-1.24